ABCL
AbCellera Biologics Inc.
Recent 8-K filings for ABCL
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 11, 2026 20:11 UTC earnings item 2.02item 7.01item 9.01
AbCellera reports Q1 net loss $43.2M; positive Phase 1 data for ABCL635 supports monthly dosing
source · ABCL on sec.gov